RxDoctor Payments Data

Beth Buscher, MD

Dermatology · Newtown, CTNPI 1427053776

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.3% of the total across 537 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 36.1% of the total.

$10,953in general payments, 2019–2025

Across 537 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novartis$842
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$834
  • Johnson & Johnson$719
  • Galderma Laboratories, L.p.$689
  • LEO Pharma Inc.$587
  • plus $3K from 28 others

What the payments were for

  • Consulting fees$1,0009%
  • Food & beverage$9,89290%
  • Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,953 in reported general payments places this provider in the 75th percentile of 222 dermatology providers in Connecticut.

See all dermatology providers in Connecticut

Medicare billing

Part B allowed, 2024
$359,949
Medicare patients
1,364
Services billed
6,412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab26$183,663
Triamcinolone Acetonide333$2,856
Metronidazole53$2,670
Betamethasone Dipropionate60$2,403
Ketoconazole106$1,564
Azelaic Acid12$1,392
Clobetasol Propionate23$1,168
Fluorouracil16$1,106
ValacyclovirValacyclovir Hcl41$937
Nystatin65$928
Mometasone Furoate52$913
Minoxidil148$704
Minocycline Hcl21$668
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc24$606
Fluocinonide12$555

Paid to pharmacies, not to this prescriber.

Other dermatology in Newtown

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →